Read and Download eBook Full
Author: Jeffrey L. Cummings
Publisher: Cambridge University Press
Published: 2012-07-26
Total Pages: 185
ISBN-13: 1107405874
DOWNLOAD EBOOKAn essential update of clinical trials in the management of neurological and neuropsychiatric disorders.
Author: Jeffrey L. Cummings
Publisher: Cambridge University Press
Published: 2007-04-12
Total Pages: 298
ISBN-13: 9780521862547
DOWNLOAD EBOOKAn essential update of recent clinical trials in the management of neurological and neuropsychiatric disorders.
Author: Jeffrey L. Cummings
Publisher: Cambridge University Press
Published: 2008-03-06
Total Pages: 314
ISBN-13: 0521862558
DOWNLOAD EBOOKAn essential update of recent clinical trials in the management of neurological and neuropsychiatric disorders.
Author: Jeffrey L. Cummings
Publisher: Cambridge University Press
Published: 2006-04-06
Total Pages: 0
ISBN-13: 9780521862530
DOWNLOAD EBOOKPublished annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists.
Author: Jeffrey L. Cummings
Publisher: Cambridge University Press
Published: 2010-05-13
Total Pages: 299
ISBN-13: 9780511666971
DOWNLOAD EBOOKPublished annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practicing neurologists as well as clinical and translational neuroscientists.
Author: Jeffrey L. Cummings
Publisher: Cambridge University Press
Published: 2012-07-26
Total Pages: 0
ISBN-13: 9781107405806
DOWNLOAD EBOOKPublished annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists.
Author: James J. O'Donnell
Publisher: CRC Press
Published: 2019-12-13
Total Pages: 899
ISBN-13: 1351625136
DOWNLOAD EBOOKDrug Discovery and Development, Third Edition presents up-to-date scientific information for maximizing the ability of a multidisciplinary research team to discover and bring new drugs to the marketplace. It explores many scientific advances in new drug discovery and development for areas such as screening technologies, biotechnology approaches, and evaluation of efficacy and safety of drug candidates through preclinical testing. This book also greatly expands the focus on the clinical pharmacology, regulatory, and business aspects of bringing new drugs to the market and offers coverage of essential topics for companies involved in drug development. Historical perspectives and predicted trends are also provided. Features: Highlights emerging scientific fields relevant to drug discovery such as the microbiome, nanotechnology, and cancer immunotherapy; and novel research tools such as CRISPR and DNA-encoded libraries Case study detailing the discovery of the anti-cancer drug, lorlatinib Venture capitalist commentary on trends and best practices in drug discovery and development Comprehensive review of regulations and their impact on drug development, highlighting special populations, orphan drugs, and pharmaceutical compounding Multidiscipline functioning of an Academic Research Enterprise, plus a chapter on Ethical Concerns in Research Contributions by 70+ experts from industry and academia specialists who developed and are practitioners of the science and business
Author: Peter Healey
Publisher: Earthscan
Published: 2012
Total Pages: 287
ISBN-13: 1849773661
DOWNLOAD EBOOKFirst Published in 2008. Routledge is an imprint of Taylor & Francis, an informa company.
Author: Theodore A. Stern
Publisher: Elsevier Health Sciences
Published: 2024-09-02
Total Pages: 818
ISBN-13: 0443119732
DOWNLOAD EBOOKOffering user-friendly, authoritative guidance on cutting-edge psychopharmacologic and somatic treatments for psychiatric and neurologic conditions, Massachusetts General Hospital Psychopharmacology and Neurotherapeutics, 2nd Edition, helps you put today's best approaches to work for your patients. Composed of topical chapters primarily from the third edition of Stern et al.'s Massachusetts General Hospital Comprehensive Clinical Psychiatry, this fully revised resource focuses on current psychotropic treatments, electroconvulsive therapy, and neurotherapeutics, making it an ideal quick reference for psychiatrists, psychologists, internists, and nurse practitioners. - Brings you up-to-date information on key topics in the field, including the application of anticonvulsants, anxiolytics, mood stabilizers, and psychostimulants; drug–drug interactions; side effects; treatment adherence; and more. - Includes detailed coverage of antidepressants, antipsychotics, and antianxiety medications, as well as advances in caring for patients with treatment-resistant depression and new legal considerations when prescribing psychotropics. - Covers recent progress on the use of neurotherapeutic interventions, such as transcranial magnetic stimulation, vagal nerve stimulation, and deep brain stimulation. - Contains a new chapter on the pharmacotherapy of movement disorders (derived from Stern et al.'s MGH Handbook of General Hospital Psychiatry, 8th Edition). - Features a user-friendly, highly templated format with abundant boxed summaries, bulleted points, case histories, algorithms, updated references, and suggested readings. - Offers updated DSM-5-TR criteria alongside peerless, hands-on advice from members of the esteemed MGH Department of Psychiatry.
Author: Juan M. Pascual
Publisher: Cambridge University Press
Published: 2017-04-20
Total Pages: 507
ISBN-13: 1107042054
DOWNLOAD EBOOKA review of childhood neurodegenerative and other progressive but non-degenerative disorders to guide their diagnosis and management.
